Osteoporosisby Robert Marcus
Now in its third edition, Osteoporosis, is the most comprehensive, authoritative reference on this disease. Written by renowned experts in the field, this two-volume reference is a must-have for academic and medical libraries, physicians, researchers, and any company involved in osteoporosis research and development. Worldwide, 200 million women between 60-80 suffer from osteoporosis and have a lifetime risk of fracture between 30 and 40 percent continuing to make osteoporosis a hot topic in medicine. This newest edition covers everything from basic anatomy and physiology to diagnosis, management and treatment in a field where direct care costs for osteoporitic fractures in the U.S. reach up to $18 billion each year.
NEW TO THIS EDITION:
*Recognizes the critical importance of the Wnt signaling pathway for bone health
*Incorporates new chapters on osteocytes, phosphatonins, mouse genetics, and CNS and bone
*Examines essential updates on estrogen prevention and treatment and the recent results from the WHI
*Discusses the controversial topics of screening and clinical trial design for drug registration
*Includes essential updates on therapeutic uses of calcium, vitamin D, SERMS, bisphosphonates, and parathyroid hormone
* Offers critical reviews of reproductive and hormonal risk factors, ethnicity, nutrition, therapeutics, management, and economics comprising a tremendous wealth of knowledge in a single source not found elsewhere
Description: This book comprehensively explores the topic of osteoporosis from basic biology underlying normal and disease states to clinical evaluation and therapeutics.
Purpose: The purpose is to provide the first thorough discussion of osteoporosis with enough depth and breadth to make it useful for both the basic investigator and the clinician. They successfully synthesize a foundation of biology, mechanics, epidemiology, and biochemistry to describe a complex condition and then expand upon this to describe varied disease states and clinical approaches to management.
Audience: It is aimed at both the researcher and the practitioner who deal with osteoporosis. It is probably must useful to the endocrinologist, but it is also of pertinent interest to orthopedists, rheumatologists, and general practitioners, especially of the elderly.
Features: The text is liberally illustrated, with a good balance of histologic reproductions (some in color) and diagrammatic illustration of biologic principles. It is fully and currently referenced. The authors' method of organization makes it extremely easy to find information very quickly. It is also extensively cross referenced, so all pertinent information is easily available.
Assessment: This is a comprehensive reference text of osteoporosis. If read cover to cover, the reader would be educated first on basic skeletal biology, including embryology, mechanics, and biochemistry, then on epidemiology and pathophysiology, and finally to the clinical disease states of osteoporosis, with emphasis on the varied other medical conditions that complicate or contribute to the development of osteoporosis. The basic and clinical sections are kept distinctly separate, but each discussion is comprehensive and stands alone. The authors give a thorough but concise historical review of the research leading up to current understanding in the field and provide direction for future research. It is so clearly written and organized that it can be used quickly and efficiently as a reference text but is also accessible to students and others with a minimal background in endocrinology.
"...interesting, comprehensive and up-to-date: each chapter has something new and important to say..."
-JOURNAL OF BONE AND JOINT SURGERY
"...Osteoporosis is quite comprehensive; indeed, topics that typically receive brief treatment elsewhere (osteoporosis in minority groups and in men) receive entire chapters here..."
-THE NEW ENGLAND JOURNAL OF MEDICINE
- Elsevier Science
- Publication date:
- Sold by:
- Barnes & Noble
- NOOK Book
- File size:
- 45 MB
- This product may take a few minutes to download.
Meet the Author
Dr. Marcus is Professor-Emeritus, Stanford University, where he served on the full-time medical faculty for almost 25 years, before joining the Emeritus faculty in 2001. At Stanford, he was located at the Veterans Affairs Medical Center, Palo Alto California, where he served as Director of the Aging Study Unit of the Geriatrics Research, Education,&Clinical Center from 1982-2001. Dr. Marcus enjoyed a long career as a clinical investigator in the fields of bone and mineral metabolism and osteoporosis medicine. His own research interests included diagnosis and therapy of primary hyperpara-thyroidism, interactions of the parathyroid-vitamin D axis with estrogen, age-related changes in the growth hormone-IGF axis, effects of growth hormone replacement for older men and women, metabolic and musculoskeletal effects of resistance exercise in older men and women, adolescent bone acquisition, and osteoporosis therapeutics. Dr. Marcus’ laboratory was a study site for many of the pivotal clinical trials in the osteoporosis field. These include the NIH Post-menopausal Estrogen/Progestin Interventions Trial (PEPI), Merck’s Fracture Intervention Trial (FIT), Lilly’s Multiple Outcomes of Raloxifene Intervention (MORE), and Lilly’s registration trial of recombinant PTH(1-34) in the treatment of postmenopausal women with osteoporosis. In 2001. Dr. Marcus joined the US Affiliate of Eli Lilly&Company to support Lilly’s program in Osteoporosis and Skeletal Medicine. From 2003 until his retirement from Lilly in 2008, Dr. Marcus was the lead physician for the Forteo team at Lilly. He has published more than 150 research papers, editorials, and reviews. Dr. Marcus served as President of the American Society for Bone&Mineral Research in 2000-2001.
Dr. Rosen is Professor and Senior Scientists at The Jackson Laboratory, Bar Harbor, Maine, where his group studies the role of insulin-like growth factors on bone and the genetics of osteoporosis in inbred strains of mice. In 2007 he joined the Maine Medical Center Research Institute in Scarborough, Maine. He is also the former Director of the Maine Center for Osteoporosis Research and Education, St. Joseph Hospital, Bangor.
Dr. Rosen is a Past President of the American Society of Bone and Mineral Research (ASBMR). He served five years as the First Editor in Chief of the Journal of Clinical Densitometry, the official journal for the International Society of Clinical Densitometry, and currently serves as Associate Editor of the Journal of Bone and Mineral Research. His publications exceed 270 manuscripts published in a wide spectrum of clinical and basic science journals.
and post it to your social network
Most Helpful Customer Reviews
See all customer reviews >